Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-811-1 | CAS number: 74-79-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vitro
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
- Justification for type of information:
- JUSTIFICATION FOR DATA WAIVING
To behave as a contact allergen, a substance must penetrate into the skin and react with proteins. L-arginine is a normal constituent of living cells as a free amino acid, bound to RNA and incorporated in proteins and peptides. Therfore, it is highly improbable that L-arginine acts as a skin sensitizing agent.
Further, L-arginine is used in parenteral nutrition, as a dietary supplement, in biochemical research, in cell culture media, as a feed additive, as an excipient in medicinal products, is a component found in skin cosmetics, is a fragrance ingredient and used as a hair conditioning agent.
Based on the available information, there is no human or animal data that indicates L-arginine to be a skin sensitiser. Considering the extensive, widespread dermal exposure to L-arginine in preparations repeatedly applied to the skin or being in contact with the skin, the absence of case reports of humans showing skin reactions is consistent with L-arginine having a very low skin sensitisation potential.
Structural alerts for skin sensitisation were derived in a database which classified as strong or moderate sensitizers. These were the chemicals which would be classified according to the criteria of the Dangerous Substance Directive 67/548/EEC. For the identification of structural alerts, the chemicals were divided into groups, on the basis of reaction mechanisms or by empirical derivation: a) acylating agents; b) alkylating/arylating agents, c) "Michael" electrophiles and precursors; e) free radical generators; d) aldehydes and precursors, f) "thiol-exchange" agents; and g) others (empirical). Forty rules (structural alerts were identified from these group of chemicals. (see: de Silva et al, 1996; Klaschka and Voßmann, 1994).
L-arginine do not contain any of this structural alerts in its chemical structure.
In accordance with REACH Annex XI No. 8.3. column 1 the assessment of this endpoint shall comprise as the first step an assessment of the available human, animal and other data. These data reveal that in vivo testing is not required in accordance with REACH and animal welfare.
de Silva D. et al (1996): Alternative Methods for Skin Sensitisation testing. The report and recommendations of ECVAM Workshop 19. ATLA 24, 683 - 705
Klaschka F. und Voßmann D. (1994): Kontaktallergene.Erich-Schmidt-Verlag, Berlin
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
Skin sensitization is the process following the epicutaneous application of a substance to the skin which results in an immunological response specific for this substance. Skin sensitisation is also called "delayed contact hypersensitivity", "contact hypersensitivity", "contact allergy" or "allergic contact dermatitis".
To behave as a contact allergen, a substance must penetrate into the skin and react with proteins. L-arginine is a normal constituent of living cells as a free amino acid, bound to RNA and incorporated in proteins and peptides. Therfore, it is highly improbable that L-arginine acts as a skin sensitizing agent.
Further, L-arginine is used in parenteral nutrition, as a dietary supplement, in biochemical research, in cell culture media, as a feed additive, as an excipient in medicinal products, is a component found in skin cosmetics, is a fragrance ingredient and used as a hair conditioning agent.
Based on the available information, there is no human or animal data that indicates L-arginine to be a skin sensitiser. Considering the extensive, widespread dermal exposure to L-arginine in preparations repeatedly applied to the skin or being in contact with the skin, the absence of case reports of humans showing skin reactions is consistent with L-arginine having a very low skin sensitisation potential.
Structural alerts for skin sensitisation were derived in a database which classified as strong or moderate sensitizers. These were the chemicals which would be classified according to the criteria of the Dangerous Substance Directive 67/548/EEC. For the identification of structural alerts, the chemicals were divided into groups, on the basis of reaction mechanisms or by empirical derivation: a) acylating agents; b) alkylating/arylating agents, c) "Michael" electrophiles and precursors; e) free radical generators; d) aldehydes and precursors, f) "thiol-exchange" agents; and g) others (empirical). Forty rules (structural alerts were identified from these group of chemicals. (see: de Silva et al, 1996; Klaschka and Voßmann, 1994).
L-arginine do not contain any of this structural alerts in its chemical structure.
In accordance with REACH Annex XI No. 8.3. column 1 the assessment of this endpoint shall comprise as the first step an assessment of the available human, animal and other data. These data reveal that in vivo testing is not required in accordance with REACH and animal welfare.
de Silva D. et al (1996): Alternative Methods for Skin Sensitisation testing. The report and recommendations of ECVAM Workshop 19. ATLA 24, 683 - 705
Klaschka F. und Voßmann D. (1994): Kontaktallergene.Erich-Schmidt-Verlag, Berlin
Migrated from Short description of key information:
L-arginine is not sensitising.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
Experience from the handling of L-arginine in industrial and commercial surroundings strongly indicate that the substance is not sensitising via the respiratory route. Studies on this endpoint are not available.
Migrated from Short description of key information:
Experience from the handling of L-arginine in industrial and commercial surroundings strongly indicate that the substance is not sensitising via the respiratory route.
Justification for classification or non-classification
L-arginine is considered as non sensitising and does not trigger respective classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.